The rise in pertussis cases urges replacement of chemically-inactivated with genetically-inactivated toxoid for DTP

This publication has 58 references indexed in Scilit:

• Characterization of Serological Responses to Pertussis
  Clinical and Vaccine Immunology, 2006
• The Diphtheria and Pertussis Components of Diphtheria‐Tetanus Toxoids–Pertussis Vaccine Should Be Genetically Inactivated Mutant Toxins
  The Journal of Infectious Diseases, 2005
• Establishment of Diagnostic Cutoff Points for Levels of Serum Antibodies to Pertussis Toxin, Filamentous Hemagglutinin, and Fimbriae in Adolescents and Adults in the United States
  Clinical and Vaccine Immunology, 2004
• Reduction of Antibody Response to an 11-Valent Pneumococcal Vaccine Coadministered with a Vaccine Containing Acellular Pertussis Components
  Infection and Immunity, 2004
• Impact of routine vaccination with a pertussis toxoid vaccine in Denmark
  Vaccine, 2004
• Correlation between Pertussis Toxin IgG Antibodies in Postvaccination Sera and Subsequent Protection against Pertussis
  The Journal of Infectious Diseases, 2000
• Acquisition of serum antibodies against filamentous hemagglutinin and pertactin unrelated to Bordetella pertussis infection
  Clinical Microbiology and Infection, 1999
• Randomised controlled trial of two-component, three-component, and five-component acellular pertussis vaccines compared with whole-cell pertussis vaccine
  The Lancet, 1997
• Pertussis in the Adult
  Annual Review of Medicine, 1977
• An immunofluorescence study of the action of antibody in experimental intracerebral infection of mice with Bordetella pertussis
  The Journal of Pathology and Bacteriology, 1966